PepGen Inc.(PEPG)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PEPG PepGen Inc.

交易中 05-19 14:08:03 EDT

1.41

-0.06

-4.08%

最高1.47	最低1.40	成交量42.06万
今开1.45	昨收1.47	日振幅4.42%
总市值9,745万	流通市值6,455万	总股本6,912万
成交额59.83万	换手率0.92%	流通股本4,578万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PEPG","market":"US","secType":"STK","nameCN":"PepGen Inc.","latestPrice":1.41,"timestamp":1779214066782,"preClose":1.47,"halted":0,"volume":420574,"delay":0,"changeRate":-0.04081632653061228,"floatShares":45776899,"shares":69115292,"eps":-1.511087,"marketStatus":"交易中","change":-0.06,"latestTime":"05-19 14:08:03 EDT","open":1.45,"high":1.465,"low":1.4,"amount":598287.6698722,"amplitude":0.044218,"askPrice":1.42,"askSize":979,"bidPrice":1.41,"bidSize":1639,"shortable":3,"etf":0,"ttmEps":-1.511087,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1779220800000},"marketStatusCode":2,"adr":0,"listingDate":1651809600000,"exchange":"NASDAQ","adjPreClose":1.47,"preHourTrading":{"tag":"盘前","latestPrice":1.47,"preClose":1.47,"latestTime":"09:29 EDT","volume":396,"amount":589.129992,"timestamp":1779197399030,"change":0,"changeRate":0,"amplitude":0.07483},"postHourTrading":{"tag":"盘后","latestPrice":1.48,"preClose":1.47,"latestTime":"18:14 EDT","volume":6667,"amount":9975.5999,"timestamp":1779142490666,"change":0.01,"changeRate":0.006803,"amplitude":0.020408},"volumeRatio":0.592942,"impliedVol":0.6956,"impliedVolPercentile":0.1514},"requestUrl":"/m/hq/s/PEPG","defaultTab":"news","newsList":[{"id":"1171698435","title":"PepGen Inc. 签署新销售协议取代旧协议 原协议已终止 - 美国证监会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1171698435","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171698435?lang=zh_cn&edition=full","pubTime":"2026-05-20 00:05","pubTimestamp":1779206720,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会（SEC）的文件，生物技术公司PepGen Inc. 已签署一项新的销售协议，该协议将完全取代公司先前存在的销售安排。随着新协议的生效，原有的销售协议已被正式终止。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112138935","title":"PepGen公布2期Freedom2研究最低剂量组积极数据：安全性、剪接效率与VHOT指标表现亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1112138935","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112138935?lang=zh_cn&edition=full","pubTime":"2026-03-31 04:06","pubTimestamp":1774901204,"startTime":"0","endTime":"0","summary":"生物技术公司PepGen Inc.今日宣布，其正在进行的2期Freedom2临床试验中最低剂量组的顶线结果展现出令人鼓舞的数据。该队列在安全性、外显子剪接效率及VHOT生物标志物三个核心维度均呈现积极信号，为后续剂量探索奠定了坚实基础。同时，靶向外显子剪接效率达到预期阈值，证明该剂量已具备生物学活性。此次低剂量组的成功为后续中高剂量组的数据解读提供了重要参照。目前Freedom2研究仍在持续推进中，后续结果将备受行业关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123269998","title":"PepGen Inc.重申指导计划：2026年一季度公布Freedom-2试验5毫克/公斤队列数据，下半年公布10毫克/公斤队列数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1123269998","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123269998?lang=zh_cn&edition=full","pubTime":"2026-03-05 05:04","pubTimestamp":1772658259,"startTime":"0","endTime":"0","summary":"生物技术公司PepGen Inc.近日再次确认其临床开发时间表，明确表示将于2026年第一季度发布Freedom-2临床试验中5毫克/公斤剂量组的研究数据。这一时间节点的重申为关注神经肌肉疾病治疗领域的投资者提供了明确预期。\n此外，针对更高剂量的10毫克/公斤队列，公司计划在2026年下半年公布相关临床结果。两个关键数据集的陆续披露，将逐步揭示其候选疗法在杜氏肌营养不良症患者中的安全性与有效性表现。\n此次指引的维持，反映了公司对临床开发进程的严格控制力，也为市场评估PepGen Inc.的技术平台价值和药物开发潜力提供了重要时间坐标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105353241","title":"PepGen Inc. 获监管批准在韩国、澳大利亚和新西兰启动Freedom2试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1105353241","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105353241?lang=zh_cn&edition=full","pubTime":"2026-03-05 05:04","pubTimestamp":1772658259,"startTime":"0","endTime":"0","summary":"PepGen Inc. 已获得监管机构的批准，将在韩国、澳大利亚和新西兰启动其Freedom2临床试验项目。这一进展标志着该公司在拓展全球临床开发版图方面迈出了重要一步，为相关地区患者参与创新疗法研究提供了可能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611971959","title":"Pepgen Inc.盘中异动 股价大涨5.41%报6.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611971959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611971959?lang=zh_cn&edition=full","pubTime":"2026-02-12 22:30","pubTimestamp":1770906640,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日22时30分，Pepgen Inc.股票出现波动，股价大幅上涨5.41%。截至发稿，该股报6.04美元/股，成交量1.9767万股，换手率0.03%，振幅2.27%。Pepgen Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212223040a49ce6ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260212223040a49ce6ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610265215","title":"Pepgen Inc.盘中异动 早盘急速下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610265215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610265215?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:43","pubTimestamp":1770648225,"startTime":"0","endTime":"0","summary":"北京时间2026年02月09日22时43分，Pepgen Inc.股票出现波动，股价快速下跌5.13%。截至发稿，该股报4.25美元/股，成交量3.4237万股，换手率0.05%，振幅5.25%。Pepgen Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020922434597a58285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020922434597a58285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602030288","title":"Pepgen Inc.盘中异动 大幅跳水5.04%报6.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602030288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602030288?lang=zh_cn&edition=full","pubTime":"2026-01-10 03:36","pubTimestamp":1767987401,"startTime":"0","endTime":"0","summary":"北京时间2026年01月10日03时36分，Pepgen Inc.股票出现波动，股价大幅下跌5.04%。截至发稿，该股报6.40美元/股，成交量23.7491万股，换手率0.35%，振幅8.12%。Pepgen Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011003364297a1580f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011003364297a1580f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165988186","title":"PepGen根据纳斯达克上市规则5635(C)(4)向新任首席商务及法律官授予激励性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1165988186","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165988186?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:03","pubTimestamp":1765281805,"startTime":"0","endTime":"0","summary":"PepGen根据纳斯达克上市规则5635(C)(4)向新任首席商务及法律官授予激励性股票","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518789032","title":"Pepgen Inc.盘中异动 早盘快速下跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518789032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518789032?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:48","pubTimestamp":1741614531,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时48分，Pepgen Inc.股票出现波动，股价快速下跌5.42%。Pepgen Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2688.82%、609.84%、93.43%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214852abf302e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214852abf302e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517166071","title":"Pepgen Inc.盘中异动 早盘急速跳水5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166071?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:30","pubTimestamp":1741271459,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时30分，Pepgen Inc.股票出现异动，股价急速下挫5.81%。Pepgen Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223059963c4c5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223059963c4c5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517415799","title":"Pepgen Inc.盘中异动 股价大涨5.26%报2.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517415799","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517415799?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:10","pubTimestamp":1741191003,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时10分，Pepgen Inc.股票出现波动，股价大幅拉升5.26%。截至发稿，该股报2.40美元/股，成交量16.0692万股，换手率0.49%，振幅9.65%。Pepgen Inc.股票所在的生物技术行业中，整体涨幅为1.33%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306001003abe9cf42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306001003abe9cf42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516340636","title":"Pepgen Inc.盘中异动 股价大跌6.35%报2.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516340636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516340636?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012436,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Pepgen Inc.股票出现异动，股价急速下挫6.35%。截至发稿，该股报2.95美元/股，成交量27.3151万股，换手率0.84%，振幅3.49%。Pepgen Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Alto Neuroscience, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为47.62%、28.82%、26.78%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Spruce Biosciences, Inc.，振幅分别为29.35%、21.22%、19.25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223356a25d407b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223356a25d407b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516379841","title":"Pepgen Inc.2024财年实现净利润-89.98百万美元，同比减少14.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516379841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516379841?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:00","pubTimestamp":1740758438,"startTime":"0","endTime":"0","summary":"3月1日，Pepgen Inc.公布财报，公告显示公司2024财年净利润为-89.98百万美元，同比减少14.43%；其中营业收入为0.00美元，每股基本收益为-2.85美元。从资产负债表来看，Pepgen Inc.总负债32.26百万美元，其中短期债务3.09百万美元，资产负债比为0.05，流动比率为0.08。机构评级：截至2025年3月1日，当前有5家机构对Pepgen Inc.目标价做出预测，其中目标均价为12.20美元，其中最低目标价为3.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000047a25817fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000047a25817fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514863378","title":"Pepgen Inc.盘中异动 早盘股价大跌5.35%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514863378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514863378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753138,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Pepgen Inc.股票出现波动，股价大幅跳水5.35%。截至发稿，该股报2.30美元/股，成交量128.473万股，换手率3.93%，振幅5.96%。Pepgen Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223219989679f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223219989679f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385987","title":"Pepgen Inc.盘中异动 早盘股价大涨5.18%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385987?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666748,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Pepgen Inc.股票出现异动，股价快速上涨5.18%。截至发稿，该股报1.61美元/股，成交量5.7239万股，换手率0.18%，振幅5.84%。Pepgen Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272232299632b0ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272232299632b0ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514013895","title":"Pepgen Inc.盘中异动 快速跳水5.24%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013895?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:33","pubTimestamp":1740494038,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时33分，Pepgen Inc.股票出现波动，股价急速下跌5.24%。Pepgen Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为761.29%、472.53%、245.35%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Dominari Holdings Inc.，振幅分别为20.51%、14.67%、11.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223358962ff2fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223358962ff2fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513172789","title":"Pepgen Inc.盘中异动 早盘股价大涨105.84%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513172789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513172789?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407484,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，Pepgen Inc.股票出现异动，股价急速拉升105.84%。Pepgen Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223124abdb0dad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223124abdb0dad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513872121","title":"PepGen(PEPG.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.68美元，前值为-0.81美元，预期值为-0.72美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513872121","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513872121?lang=zh_cn&edition=full","pubTime":"2025-02-24 21:51","pubTimestamp":1740405103,"startTime":"0","endTime":"0","summary":"PepGen(PEPG.US)：2024年Q4财报实现营收0美元，前值为0美元；每股收益为-0.68美元，前值为-0.81美元，预期值为-0.72美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24215148352672.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PEPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513214027","title":"Pepgen Inc.盘中异动 下午盘大幅跳水6.25%报1.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513214027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513214027?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:21","pubTimestamp":1740169307,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时21分，Pepgen Inc.股票出现波动，股价大幅跳水6.25%。截至发稿，该股报1.35美元/股，成交量14.9746万股，换手率0.46%，振幅8.33%。Pepgen Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222042147a24ef873&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222042147a24ef873&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512833254","title":"Pepgen Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512833254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512833254?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:38","pubTimestamp":1739975884,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时38分，Pepgen Inc.股票出现异动，股价快速上涨5.00%。Pepgen Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Pepgen Inc.公司简介：PepGen Inc 是一家临床阶段的生物技术公司，致力于推进下一代寡核苷酸治疗药物，以改变严重神经肌肉和神经系统疾病的治疗方式。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192238049628ce84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192238049628ce84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PEPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pepgen.com","stockEarnings":[{"period":"1week","weight":-0.1353},{"period":"1month","weight":-0.1353},{"period":"3month","weight":-0.7835},{"period":"6month","weight":-0.7342},{"period":"1year","weight":-0.0455},{"period":"ytd","weight":-0.7742}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"PepGen Inc.于2018年1月25日在美国特拉华州成立。该公司是一家临床阶段的生物技术公司，推进下一代寡核苷酸疗法，目标是改变严重神经肌肉和神经系统疾病的治疗。他们在十多年的研究和开发基础上增强型寡核苷酸或建立EDO平台，并利用细胞穿透肽来提高偶联寡核苷酸疗法的吸收和活性。 这项技术最初是由牛津大学的研究人员与英国研究与创新医学研究委员会合作开发的。他们正在使用这些EDO肽生产一系列寡核苷酸治疗候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.057082},{"month":2,"riseRate":0.75,"avgChangeRate":0.580465},{"month":3,"riseRate":0,"avgChangeRate":-0.400307},{"month":4,"riseRate":0.5,"avgChangeRate":0.028304},{"month":5,"riseRate":0.25,"avgChangeRate":0.037198},{"month":6,"riseRate":0,"avgChangeRate":-0.194547},{"month":7,"riseRate":0.5,"avgChangeRate":-0.062921},{"month":8,"riseRate":0.25,"avgChangeRate":-0.102699},{"month":9,"riseRate":0.25,"avgChangeRate":0.658187},{"month":10,"riseRate":0.75,"avgChangeRate":0.035806},{"month":11,"riseRate":0.5,"avgChangeRate":0.080021},{"month":12,"riseRate":0.5,"avgChangeRate":0.010709}],"exchange":"NASDAQ","name":"PepGen Inc.","nameEN":"PepGen Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PepGen Inc.(PEPG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供PepGen Inc.(PEPG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"PepGen Inc.,PEPG,PepGen Inc.股票,PepGen Inc.股票老虎,PepGen Inc.股票老虎国际,PepGen Inc.行情,PepGen Inc.股票行情,PepGen Inc.股价,PepGen Inc.股市,PepGen Inc.股票价格,PepGen Inc.股票交易,PepGen Inc.股票购买,PepGen Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PepGen Inc.(PEPG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供PepGen Inc.(PEPG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}